Skip to main content
. 2006 Feb;143(2):209–215. doi: 10.1111/j.1365-2249.2005.02986.x

Table 1.

Echocardiographic parameters 12 months after immunization with H26R.

H26R immunized (n = 7) Controls (n = 7) P-value
HR (beats/min) 342 ± 10 366 ± 9 n.s.
CO (ml/min) 165 ± 2 164 ± 2 n.s.
LVD (mm) 9·0 ± 0·3 9·1 ± 0·2 n.s.
LVS (mm) 6·4 ± 0·2 5·7 ± 0·3 0·08
Posterior wall thickness in end-diastole (mm) 1·53 ± 0·13 1·50 ± 0·07 n.s.
IVSd 1·3 ± 0·3 1·3 ± 0·4 n.s.
FS (%) 31·2 ± 1·1 37·4 ± 2·5 0·02*
Circumferential shortening (circ/s) 3·92 ± 0·16 5·17 ± 0·42 0·012*

Data are given as mean ± s.e.m.. Differences between groups were calculated with the Mann–Whitney test, * P < 0·05. HR = heart rate; CO = cardiac output (stroke volume · heart rate); LVD = left ventricle end-diastolic diameter; LVS = left ventricle end-systolic diameter; PWd = posterior wall diameter; IVSd = intraventricular septum thickness in end diastole; FS = fractional shortening (LVD-LVS/LVD × 100); circumferential fibre shortening (fraction shortening/ejection time).